Abbott (ABT) Tops Q4 EPS by 1c, FY16 EPS Falls Short of Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
UBS Remains Neutral on Abbott (ABT) Following 4Q Earnings and Conference Call
February 1, 2016 8:33 AM ESTUBS maintained a Neutral rating on Abbott Labs (NYSE: ABT), and cut the price target to $41.00 (from $43.00), following the company's 4Q earnings report. Street estimates suggested a lower 2016 outlook, driven by tougher FX in geographies where ABT has fewer natural hedges. However, the volume slowdown in oildriven economies like Venezuela took another dime or so out of the 2016 EPS... More
William Blair Downgrades Abbott Labs (ABT) to Market Perform
January 29, 2016 7:28 AM ESTWilliam Blair downgraded Abbott Labs (NYSE: ABT) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.
Shares of Abbott Labs closed at $36.71 yesterday.
... More